# Xavier RCMI Renewal Application-Research Infrastructure Core

> **NIH NIH U54** · XAVIER UNIVERSITY OF LOUISIANA · 2021 · $1,025,494

## Abstract

Summary of Research Infrastructure Core
The RCMI Cancer Research Center aims to enhance the quality and productivity of Xavier’s basic biomedical
and behavior research in the focus area of cancer and cancer-related health disparities by establishing a
Research Infrastructure Core (RIC) that will have shared instrumentation, drug discovery and delivery
programs, cell and molecular biology facilities, and bioinformatics services. The current core resources build on
the previous three RCMI core laboratories that served Xavier investigators and helped expand the research
capacity in the last decade. Based on the assessment of strengths and weaknesses in the current research
portfolio of Xavier investigators, the RIC will implement new rules of prioritization, revised and improved
standard operation procedures, and more effective management of core facilities including convergence of
cross disciplinary expertise and cost recovery systems. The RIC will maximally benefit Xavier investigators
across all health-related research areas by achieving three specific aims: Aim 1. Acquire, maintain, and
operate shared analytical and bioanalytical instrumentation that will be utilized by not only the basic biomedical
research projects and pilot projects to be funded by the current RCMI application, but also all Xavier
investigators across a broad range of health-related research areas. The RIC will provide essential
instrumental and technical support for Xavier’s biomedical research projects that rely on the availability of
functioning major equipment. Aim 2. Form a faculty expertise group (FEG) to provide faculty-level expertise in
research methodology, specialized laboratory techniques, statistics, bioinformatics and health informatics. The
FEG will consist of senior faculty members with research expertise in experimental design and research
strategy on drug discovery and formulation, cell and molecular biology, mechanistic investigations, and data
processing using various bioinformatics and biostatistics tools drug discovery, drug delivery, cell and molecular
biology, bioinformatics, and analytical instrumentation. Aim 3. Implement an effective cost recovery program for
the Research Infrastructure Core. RIC will continue to use a fee charging system started in 2012. The FEG will
oversee the charge back process and maintain account balance. The fees collected will continue to be used to
partially defray the cost of consumable parts and unexpected repair costs needed for the core facilities.
Additional measures will be implemented to increase cost recovery of core facilities by underwriting core staff
efforts in external grant applications by Xavier investigators.

## Key facts

- **NIH application ID:** 10078880
- **Project number:** 5U54MD007595-13
- **Recipient organization:** XAVIER UNIVERSITY OF LOUISIANA
- **Principal Investigator:** Vladimir Kolesnichenko
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,025,494
- **Award type:** 5
- **Project period:** 2009-09-24 → 2023-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10078880

## Citation

> US National Institutes of Health, RePORTER application 10078880, Xavier RCMI Renewal Application-Research Infrastructure Core (5U54MD007595-13). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10078880. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*